At a glance
ClinicalIndex Comparison Record- ✓Diagnosed with COPD (documented in electronic health record)
- ✓Current daily smokers: 5+ cigarettes per day over past 30 days
- ✓Intent to quit smoking within next 60 days
- ✓At least moderate smoking for affective regulation (SMQ-R coping subscale ≥30)
- ✕Medical or psychiatric conditions precluding informed consent or study procedures (e.g., moderate-to-severe dementia, severe uncontrolled schizophrenia)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
In Brief
A clinical study evaluating Unified Protocol adapted for smoking cessation for Copd and 4 related conditions. Completed, enrolled 18 participants across 1 site.
Detailed Summary
Chronic Obstructive Pulmonary Disease (COPD) is caused primarily by smoking and smoking cessation is the first-line treatment for slowing disease progression. Despite this, nearly 50% of COPD patients continue to smoke following diagnosis. Smokers with COPD report high rates of co-occurring conditions - nicotine dependence, depression, and anxiety - which serve as barriers to quitting. The current study will pilot test a behavioral intervention designed to target the common psychological factors underlying these co-occurring conditions and foster smoking cessation among COPD patients.
Study Details
Timeline
Interventions
Treatment components are cognitive-behavioral strategies adapted from the Unified Protocol (UP) for the Transdiagnostic Treatment of Emotional Disorders. Behavioral counseling strategies for smoking cessation, drawn from current US Public Health Service guidelines, are incorporated in each treatment module. All participants will be provided with the American Lung Association Freedom from Smoking guide to aid in their quit attempt.